Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of gut microbiota in cancer treatment: friend or foe?
Wing Yin Cheng, Chun‐Ying Wu, Jun Yu
Gut (2020) Vol. 69, Iss. 10, pp. 1867-1876
Open Access | Times Cited: 259

Showing 1-25 of 259 citing articles:

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 167
Applications of multi‐omics analysis in human diseases
Chongyang Chen, Jing Wang, Donghui Pan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 150
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies
P Oster, Laurie Vaillant, Erika Riva, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 457-466
Open Access | Times Cited: 132
Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages
Yaxin Chen, Yanzhuo Liu, Yang Wang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 132
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 111
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Qin Qiu, Yuqi Lin, Yucui Ma, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 106
Immune checkpoint inhibitor resistance in hepatocellular carcinoma
Zhijie Wang, Yichuan Wang, Peng Gao, et al.
Cancer Letters (2022) Vol. 555, pp. 216038-216038
Closed Access | Times Cited: 80
Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review
Henan Zhang, Fuchun Jiang, Jinsong Zhang, et al.
International Journal of Biological Macromolecules (2022) Vol. 204, pp. 169-192
Closed Access | Times Cited: 76
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives
Mohamed E. Abouelela, Yosra A. Helmy
Microorganisms (2024) Vol. 12, Iss. 3, pp. 430-430
Open Access | Times Cited: 47
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Mohamed Kamel, Sami Aleya, Majed Alsubih, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 217-217
Open Access | Times Cited: 18
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
Ajeeth K. Pingili, Mehdi Chaib, Laura M. Sipe, et al.
Cell Reports (2021) Vol. 35, Iss. 12, pp. 109285-109285
Open Access | Times Cited: 76
Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets
Anderson dos Santos Ramos, Giovana Cristina Santana Viana, Marcelo M. Brígido, et al.
Pharmacological Research (2021) Vol. 171, pp. 105779-105779
Closed Access | Times Cited: 68
Microbiota and prostate cancer
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 1058-1065
Closed Access | Times Cited: 66
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim, Helena Kupcová Skalníková, Jana Čížková, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 63
Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer
Huajing Teng, Yan Wang, Xin Sui, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 124-138.e6
Open Access | Times Cited: 62
Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia
Caijun Zhao, Xiaoyu Hu, Lijuan Bao, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 55
The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer
Azin Aghamajidi, Saman Maleki Vareki
Cancers (2022) Vol. 14, Iss. 15, pp. 3563-3563
Open Access | Times Cited: 54
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Jiayuan Huang, Wenting Liu, Wanying Kang, et al.
EBioMedicine (2022) Vol. 83, pp. 104197-104197
Open Access | Times Cited: 53
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan, Anna Mondino
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004147-e004147
Open Access | Times Cited: 52
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 50
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
Hebin Che, Qi Xiong, Jinxia Ma, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 49
Global research trends on the links between the gut microbiome and cancer: a visualization analysis
Sa’ed H. Zyoud, Samah W. Al‐Jabi, Riad Amer, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top